Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

The participants were implanted with a pacemaker-like device, under the skin in the chest that stimulated their left vagus ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

Quetiapine is an antipsychotic medication that people who live with schizophrenia or bipolar rely on. Pharmacists say they ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

Vagus nerve stimulation (VNS) shows a positive treatment effect and improved quality of life (QoL) among patients with ...